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Abstract 
Cardiac magnetic resonance imaging (MRI) has emerged as a prime player in the clinical and preclinical detection of 
ischemic heart disease (IHD) as well in the prognosis assessment by offering a comprehensive approach for all spectrums of 
coronary artery disease (CAD) patients. The aim of this review is to provide the reader a state-of-the art on how the newest cardiac 
MRI techniques can be used to study IHD patients. 
In patients with suspected/stable CAD, functional and perfusion imaging both at rest and during vasodilatatory stress 
(adenosine, dypiridamole)/dobutamine stress can accurately depict ischemic myocardium secondary to significant coronary artery 
stenosis. 
In patients with acute MI, MRI is a robust tool for differentiating and sizing the jeopardized and the infarcted myocardium by 
using a combination of functional, edema, perfusion and Gd contrast imaging. Moreover, important prognostic factors like myocardial 
salvage, the presence of microvascular obstruction (MVO), post reperfusion myocardial hemorrhage, RV involvement and infarct 
related complications can be assessed in the same examination. 
In patients with chronic ischemic cardiomyopathy, the role of the MRI extends from diagnosis by means of Gadolinium contrast scar 
imaging to therapy and prognosis by functional assessment and viability testing with rest and dobutamine stress imaging. 
In all the circumstances mentioned, MRI derived information has been proven valuable in every day clinical decision 
making and prognosis assessment. Thus, MRI is becoming more and more an accepted alternative to other imaging modalities both 
in the acute and chronic setting.  
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Introduction 
Although mortality associated with ischemic 
heart disease (IHD) has declined in the recent decades 
due to the therapeutic improvements and to the 
prevention campaigns reducing the incidence of 
myocardial infarction (MI), IHD remains the leading cause 
of death in adults in developed countries and its 
prevalence will continue to increase [1].         
In times of constrained financial budgets, the 
increasing prevalence of IHD will urge for rational use of 
diagnostic and therapeutic means. In the last 2 decades 
magnetic resonance imaging (MRI) has emerged as a 
prime player in the clinical and preclinical detection of IHD 
as well in the prognosis assessment [2].  
The aim of this review is to provide the reader a 
state-of-the art on how the newest cardiac MRI 
techniques can be used to study IHD patients and to 
enlarge the knowledge on the complex IHD 
pathophysiology, with highlights on detection of 
obstructive coronary artery disease (CAD), on acute 
coronary syndromes and on chronic ischemic 
cardiomyopathy. 
 
Pathophysiological considerations 
It is important to start by briefly outlining a 
number of different states, and their physiopathological 
substrates, in which acutely or chronically aggressed 
myocardial tissue can be found secondary to CAD.  
After the acute coronary occlusion, the time 
frame of events in the ischemic cascade comprises the 
reversible changes: myocardial contractile dysfunction 
(seconds), intracellular oedema (20-30 minutes of 
sustained ischemia) followed by irreversible injury to 
myocytes (30-60 minutes) and vascular endothelial 
cells (60-90 minutes) with cellular necrosis and 
apoptosis. While myocardial necrosis progresses in a 
wave front manner from the subendocardium towards the Journal of Medicine and Life Vol. 4, Issue 4, October‐December 2011 
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subepicardium (3-6 hours), making transmurality time 
dependent, the lateral boundaries of infarction closely 
correspond to the initial myocardium at risk [3].  The 
jeopardized myocardium (myocardium at risk) refers 
to the myocardium in the perfusion territory of the involved 
artery distal to the critical lesion. 
Urgent restoration of epicardial flow, which is the 
cornerstone of modern therapeutic strategies in acute MI, 
aims to salvage the jeopardized but viable myocardium in 
the myocardium at risk. Despite the beneficial effects of 
reperfusion, the process of cell death may continue during 
the first hours of reperfusion, a phenomenon called 
“myocardial reperfusion injury” [4]. The main feature of 
this complex phenomenon is the presence of 
microvascular obstruction (MVO) with a complete lack 
of tissue perfusion, despite successful epicardial 
recanalization. 
Prolonged post-ischemic contractile dysfunction 
of the myocardium salvaged by reperfusion defines the 
“stunned myocardium” which may take days to weeks to 
normalize, though it can be reversed with inotropic agents 
[5].  
Finally, the term “hibernating myocardium” is 
used to describe viable myocardium in a state of 
persistent but potentially reversible dysfunction secondary 
to a chronic coronary artery stenosis with impaired 
myocardial blood flow [6].     
 
Imaging Strategies in Ischemic Heart Disease 
Currently available cardiac MRI techniques are 
able to fulfill the aims of imaging in IHD patients: on one 
hand, anatomic imaging with visualization of CAD and 
on the other hand,  ischemia imaging with evaluation of 
the consequences of CAD to the heart, particularly 
myocardial perfusion and function and depiction of 
irreversible myocardial damage. Due to its superiority 
over MRI, cardiac computed tomography is used 
nowadays for mere visualization of coronary artery 
stenoses, cardiac MRI being primarily focused on the 
assessment of the ischemic consequences of CAD [7-9].  
In clinical practice, by using a comprehensive 
MRI approach, the above information can be obtained 
within a single examination taking not more than 30–45 
minutes.  
 
Functional Imaging 
ECG gated and acquired during breath holds, 
dynamic cine MRI (b-SSFP) sequences provide a non-
invasive, accurate and reproducible alternative to 
conventional echocardiography for calculating 
ventricular volumes and function and visualizing 
regional wall motion and contraction patterns. Thus, 
cine MRI should be considered as a fast and robust 
imaging modality for both daily clinical routine and 
research purposes [10,11]. With techniques as real-time 
non-gated cine sequences, problems like the presence 
of atrial fibrillation or the incapacity for breath holding are 
now mostly overcome.  
For volumetric and functional ventricular 
analysis, the heart is typically studied in different cardiac 
imaging planes. Hereby the ventricles are completely 
encompassed by a set of contiguous images (usually 8 to 
12), in at least one direction which is usually the short-
axis. Contouring of endo- and epicardial borders of this 
stack of images at end-diastole and end-systole provides 
global functional parameters (i.e., EDV, ESV, SV, EF and 
myocardial mass) (Fig. 1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Regional ventricular function can be assessed 
either qualitatively (normal, hypokinetic, akinetic, or 
dyskinetic) or quantitatively (relative or absolute wall 
thickening and wall motion). In order to have consensus 
between readers and imaging modalities, the 
standardized 17-segment model as proposed by the 
American Heart Association is usually used [12].  
      Further, for a more comprehensive approach of 
CAD patients, evaluation of cardiac function and 
myocardial contractility can be performed both at rest and 
under stress conditions (physical or pharmacological), i.e. 
ischemia/viability testing. Because available imaging 
time per stress level is limited, fast cine MRI sequences 
are preferable in these cases. As further shown, 
interpretation of regional motion and contraction patterns 
is usually done by looking also at other types of 
sequences like contrast-enhanced MRI (ce-MRI) with late 
gadolinium enhancement which depict acute and/or 
healed myocardial infarction [13].  
Myocardial tagging MRI techniques non-
invasively create tag or grid lines on the myocardium, 
Fig. 1. Functional analysis of short axis cine MRI. End-
diastolic (ED) and end-systolic (ES) time frames are defined 
and then the endo- and epicardial borders are manually 
drawn for each slice – in this example a midventricular slice 
is shown. Journal of Medicine and Life Vol. 4, Issue 4, October‐December 2011 
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allowing to analyze regional myocardial deformation 2- or 
3 dimensionally throughout the cardiac cycle, and to 
calculate myocardial strains (Fig. 2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A better characterization of the mechanisms of 
normal/impaired myocardial contraction is thus achieved 
but due to the elaborative post-processing, the clinical use 
of myocardial tagging MRI is currently limited [14].  
 
Myocardial Perfusion Imaging 
Basic pathophysiologic principles of coronary 
blood flow and myocardial perfusion apply also in cardiac 
MRI perfusion interpretation. Briefly, in resting conditions, 
due to the coronary vasodilator reserve, myocardial 
perfusion is not altered until the coronary artery is 85-90% 
narrowed. In contrast, during stress the myocardium distal 
to less severe coronary stenosis (i.e. between 50 to 85%) 
may become ischemic and the coronary artery stenosis 
can be considered hemodynamically significant.   
The most frequently used approach to assess 
myocardial perfusion with MRI is monitoring of the “first-
pass” of contrast medium through the heart, using a 
bolus injection of gadolinium in combination with ultra-
fast cine MR sequences. Perfusion studies can be 
performed during resting conditions and/or during 
administration of a vasodilatatory agent (i.e. adenosine or 
dipyridamole). Whereas, normally perfused myocardium 
enhances homogeneously, becoming bright, hypo-or non 
perfused regions appear dark for a variable amount of 
time during/after first-pass, are most intense in the 
subendocardium and typically respect coronary artery 
perfusion territories (Fig. 3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Edema Imaging 
Increased free water in the infarcted myocardium 
changes tissue magnetization properties (i.e. prolongs 
proton T1- and T2-relaxation) when compared to normal 
myocardium, and this change is related to the duration of 
ischemia [15]. T2-relaxation time is linearly correlated to 
the percentage of free water, and edema is visible on T2-
weighted MR sequences in infarcted myocardium as 
bright areas (hyper-intense). In acute MI patients, it is 
accepted that the bright myocardium on T2-weighted 
imaging reflects the myocardium at risk. Abnormalities 
are most evident in the acute and sub-acute phase of MI 
and slowly fade away due to processes of infarct healing 
with scar formation and resorption of infarct-related 
myocardial edema and inflammation [16]. Thus, in 
addition T2-weighted imaging distinguishes between a 
fresh and a healed MI [17]. It should be emphasized that 
other conditions such as acute myocarditis or transplant 
rejection may equally present focal or diffuse myocardial 
edema [18]. T2-weighted MR sequences, equipped with 
Fig. 2. Example of MRI study with 2D tagging analysis. 
Tagging in cardiac short axis (a,b) and horizontal long axis 
(c,d), end-diastolic (left) and end-systolic time frame (right). 
Tracking of the grid intersections (indicated in red) on the 
short axis views, and the intersections of the tags with the 
endo- and epicardial border (indicated in red) on the long-
axis views, allow analyzing the local myocardial 
deformation. 
Fig. 3. MRI stress perfusion study in a 73 old year female 
with suspected mid LAD coronary artery in-stent stenosis. 
Midventricular short-axis serial time frames of “first pass” 
perfusion during dipyridamole vasodilatatory stress show 
Gd contrast successively enhancing the right, left chambers 
and myocardium (images from left to right). A transmural 
perfusion defect in the anterior and lateral walls is seen 
(arrows). The patient was referred for catheterization which 
confirmed a 90% in-stent stenosis and was treated by PCI 
with drug eluting stent placement. Journal of Medicine and Life Vol. 4, Issue 4, October‐December 2011 
  333
inversion techniques to null the signal of fat and blood 
(will appear dark) (T2-weighted short-inversion-time 
inversion-recovery,  T2w-STIR MRI, “triple inversion-
recovery sequences”), are now most commonly used for 
edema imaging [19].  
 
Contrast Enhanced MRI 
Up to date, the paramagnetic gadolinium-
chelated contrast agents (Gd), mainly Gd- 
diethylenetriamine pentaacetic acid (DPTA), are the only 
licensed group of paramagnetic contrast agents for 
cardiac imaging routine use. Gd contrast agents have 
been extensively evaluated for MI imaging in both the 
acute and chronic setting [20,21]. This small molecule 
diffuses rapidly after intravenous injection into the 
interstitial space (strictly extracellular), and is eliminated 
by renal clearance. Due to differences in 
pharmacokinetics and distribution volume between normal 
and infarcted/scarred myocardium, the latter appears 
bright (enhanced) compared to normal myocardium which 
appears dark.       
Gadolinium contrast agents are not infarct 
specific; as such, myocardial enhancement is non-
specific, while the location and pattern of enhancement 
give important information regarding the underlying 
etiology.  
Currently, in the routine clinical setting, MI 
imaging after Gd administration is done by an inversion-
recovery T1-weighted sequence, which achieves an 
increased contrast between normal and pathological 
tissue (dark vs. bright). Using this technique, infarcted 
myocardial tissue weighting as low as 1 gram can be 
visualized (vs. 10 grams with SPECT) like, for example, in 
papillary muscle necrosis or peri-procedural myocardial 
damage [22].  
Administration of Gd contrast agents in acute MI 
results in a time-varying infarct enhancement. Infarct-
related factors and contrast agents or MRI sequences 
characteristics contribute to the “observed” enhancement. 
Among the infarct related factors a hyperemic response 
after reperfusion (increased delivery of Gd) and an 
increased myocardial distribution volume due to interstitial 
edema and myocyte disruption (intracellular diffusion of 
contrast agent) will increase Gd concentration in the 
infarcted area, while an incomplete coronary 
recanalization with a poor collateral circulation and the 
presence of MVO will act the opposite [23-25].  
Ce-MRI is a robust, well-validated and accurate 
tool to depict myocardial necrosis in the acute setting of 
MI. Following administration of contrast material, infarcted 
myocardium is visible as a time-varying enhancement 
(bright) distinguishable from normal myocardium (dark). 
However, one should comprehend that extracellular 
contrast agents are neither specific nor avid for 
myocardial necrosis.  
It is proven that in chronic CAD patients, 
myocardial enhancement in areas of dysfunctional 
myocardium corresponds closely to fixed defects on 
thallium SPECT, and areas of flow-metabolism matched 
defects on FDG-PET scans, histologically representing 
scarred or fibrotic tissue [26,27]. This technique is 
nowadays routinely used to depict infarct-related 
myocardial scarring and is helpful to differentiate dilated 
cardiomyopathy from LV dysfunction related to CAD, and 
to predict functional recovery post-coronary 
revascularization [13,28] (Fig. 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stable Coronary Artery Disease 
As already mentioned above, cardiac MRI offers 
a comprehensive non-invasive imaging approach to the 
broad chronic CAD spectrum patients, by being able to 
combine both anatomic and ischemic imaging (rest 
and stress). Due to long acquisition times and lack of 
robustness, clinical use of cardiac MRI for non-invasive 
coronary plaque detection is nowadays of limited value. 
Despite this, substantial progress has been made in 
myocardial ischemia assessment, making this technique 
an attractive and valuable alternative to stress 
echocardiography and radionuclide pharmacological 
stress perfusion imaging (i.e. SPECT imaging).  
Compared to stress echocardiography, MRI 
provides reliable image quality not limited by the 
Fig. 4. MRI study in a 58 year old male recently diagnosed 
with dilated cardiomyopathy (LV EF 20%). Still 
midventricular short-axis (a) and vertical long-axis (b) 
images of cine MRI show a remodeled, dilated LV and 
inferior wall thinning (arrows,  a,b). Late ce-MRI in the 
same imaging planes show transmural enhancement of 
the basal and mid inferior wall (c,d) and of the mid 
inferomedial RV suggesting an old inferior MI with RV 
involvement (arrow head). Coronary angiography showed 
trivessel disease with RCA occlusion. Journal of Medicine and Life Vol. 4, Issue 4, October‐December 2011 
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adequacy of the acoustic window. Per stress level, 
images can be easily acquired in standardized 
(repeatable) planes, and easily compared on an off-line 
workstation reducing operator-dependency.  
Compared to SPECT, MRI is able to give similar 
information about myocardial perfusion with superior 
spatial resolution, no radiation exposure, and in a single 
examination. Moreover, the superior spatial resolution of 
MRI permits to visualize smaller, subendocardially located 
perfusion defects not infrequently missed by SPECT [29].  
 
Stress Perfusion Imaging 
MRI perfusion studies use the “first pass” of an 
intravenously injected Gd contrast agent during 
administration of a vasodilator (i.e. adenosine or 
dipyridamole) to depict hemodynamically significant 
coronary artery stenosis (Fig. 5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
At present this technique has been well 
validated, showing similar or better accuracies when 
compared to routinely used techniques such SPECT 
imaging [29-31]. In a meta-analysis by Nandalur et al. 
including 24 studies (1516 patients, high disease 
prevalence), perfusion imaging demonstrated a sensitivity 
of 91% and a specificity of 81% [32].  
Regarding data analysis, in daily clinical practice 
stress-induced perfusion defects are usually visually 
assessed by looking at the presence of subendocardial or 
transmural hypo-intense (dark) rim during the “first-
pass” of contrast in one or more coronary artery 
perfusion territories. Semi-quantitative or quantitative 
methods have become available mainly for research 
purposes. A relatively simple semi-quantitative method 
that has been validated against coronary flow reserve 
measurements is the assessment of the myocardial 
perfusion reserve (MPR) or MPR index. MPR index is 
defined as the ratio of regional myocardial blood flow after 
induced vasodilatation to that under resting conditions 
[30,33]. For example, Rieber et al., found that by using 
fractional flow reserve in addition to the degree of 
stenosis on coronary angiography as reference modality, 
a MPR index cut-off value of 1.5 was able to distinguish 
between hemodynamically relevant and non-relevant 
coronary lesions with a sensitivity of 88% and specificity 
of 90% [34]. After PCI with stent implantation or CABG 
surgery, a significant improvement in MPR index was 
reported, thus providing information on the success of 
interventional revascularization procedures [35].  
It must be noted that first-pass perfusion is prone 
to dark-rim artifacts (dark ring at the subendocardial 
border) and these artifacts may interfere with depiction of 
subendocardial ischemia. 
 
Stress Function Imaging 
Although it is possible to perform exercise testing 
in an MR environment using a specific MR-compatible 
ergometer (supine bicycle), functional stress testing is 
usually performed during dobutamine (± atropine) 
administration [36]. Similar to dobutamine stress 
echocardiography, a stepwise dose increment of 
dobutamine is used in order to differentiate the precise 
nature of the ischemic substrate, i.e., stunned, ischemic, 
hibernated, necrotic/scarred myocardium [37,38]. 
MRI stress function imaging  protocol is 
similar to stress echocardiography; acquisition is started 
in resting conditions with cine MR images in a set of 
standardized imaging planes through the ventricles 
(usually short axis, horizontal and vertical long-axis). This 
approach allows the evaluation of regional contractility in 
all segments of the left ventricle. In addition a single 
breath-hold 3D cine MRI sequence encompassing the 
entire left ventricle is performed, allowing the calculation 
of LV volumes and ejection fraction. Next, dobutamine 
infusion is started at low dose (5 g/kg per minute) and 
increased stepwise by 100% up to 40g/kg per minute for 
ischemia testing and up to 20g/kg per minute for viability 
studies. The same images are acquired 3 minutes after 
the initiation of a new dose. The images can be 
transferred immediately after completion of a step to an 
off-line workstation and analyzed for new or worsening 
wall motion abnormalities (WMA). A peak stress first pass 
myocardial perfusion study can also be performed and it 
Fig. 5. MRI study (rest and stress perfusion) in a 52 year 
old male with stable angina. Rest and stress (*) SPECT 
were negative, showing no induced perfusion defects (a). 
Midventricular short-axis cardiac MRI images (b) of first 
pass perfusion during rest (bottom) show no perfusion 
defects while during dipyridamole vasodilatatory stress 
(top) show a subendocardial perfusion defect in the lateral 
wall (arrows). Coronary angiography (c) confirmed a 
significant (90%) stenosis of the first lateral branch of Cx 
(arrow, vessel larger than the Cx). Journal of Medicine and Life Vol. 4, Issue 4, October‐December 2011 
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has shown value particularly in patients with concentric 
LV hypertrophy and in non-ischemic patients with stress 
inducible left bundle branch block, in which wall motion 
analysis is difficult.  
With respect to adverse effects, studies have 
shown that high-dose functional stress imaging in an MR 
environment can be considered as safe and feasible in 
patients with suspected or known CAD [39]. 
The advantage of stress function MRI over 
echocardiography rests in superior image quality, with 
high spatial and temporal resolution and better inter- and 
intra-observer agreement [40]. Two studies have 
demonstrated the higher accuracy (86.0% vs. 72.7%) of 
high-dose stress dobutamine MRI compared to high-dose 
dobutamine stress echocardiography in detecting patients 
with significant CAD [41,42]. Patients with poor acoustic 
windows benefit the most from MRI stress testing.  
The most commonly used approach in ischemia 
functional stress studies is visual analysis of new or 
worsening WMA’s using a high-dose 
dobutamine/atropine regimen and a 16 (or 17) segment 
model [12] (Fig 6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This yields good sensitivities (83-96%) and 
specificities (80-100%) for detection of significant CAD 
[43].  
 
Acute Coronary Syndromes 
The diagnostic tools available at the moment of 
presentation of an acute coronary syndrome: blood 
biomarkers, electrocardiography and echocardiography, 
only provide a partial insight into the complex, evolving 
processes in the jeopardized myocardium. Cardiac MRI 
allows an accurate appraisal of the myocardium in the first 
hours after the onset of chest pain providing substantial 
complementary information to standard imaging 
modalities.  
 
Characterization of the Jeopardized Myocardium 
The  myocardium (area) at risk is a major 
determinant of infarct size, because it predicts the 
maximal area of myocardium that is at risk for necrosis. It 
is known that the anatomical site of occlusion of the 
coronary artery does not reliably predict the size of the 
area at risk [44]. Although angiographic criteria were 
assessed to estimate more accurately the jeopardized 
myocardium, for example by using the Bypass 
Angioplasty Revascularization Investigation Myocardial 
Salvage Index (BARI), there is need for imaging 
techniques that can directly and accurately depict this 
area at risk [45,46]. 
Edema imaging by T2-weighted sequences is 
at present one of the most appealing techniques to non-
invasively assess the myocardium at risk [47]. This can be 
determined retrospectively, i.e. post-reperfusion, by T2-
weighted edema imaging, with abnormalities present at 
least one week after the acute event [16]. Abdel-Aty et al., 
recently showed that edema imaging depicts acute 
ischemic injury within the first 30 minutes after onset of 
ischemia, before the onset of irreversible myocardial 
injury (i.e. troponin elevation, late Gd enhancement) [47]. 
Since the development of myocardial edema is an early 
feature in acute coronary syndromes, adding T2-weighted 
imaging to the MRI exam in unstable angina or MI 
patients, may serve as a very useful diagnostic marker in 
the emergency department [48].             
As mentioned above, edema imaging is not MI 
specific and in the acute setting of cardiac-related chest 
pain, patients with Tako-Tsubo cardiomyopathy and acute 
myocarditis may show also myocardial edema (Fig. 7).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ce-MRI is a valuable tool for detailed infarct 
imaging. Myocardial enhancement after Gd contrast 
administration within the jeopardized myocardium reflects 
mainly irreversibly damaged tissue that will be lost 
[23,24,49]. Myocardial contrast wash-in and wash-out are 
dynamic processes, so one of the most important factors 
in imaging post contrast administration is timing [50]. The 
optimal time window for infarct imaging being between 10 
Fig. 6. MRI study (dobutamine-atropine stress) in 60-year-
old man. Midventricular cardiac short-axis cine MRI at end-
diastole (a), end-systole (b), and isovolumic relaxation (c). 
At maximal stress, during systole (b), the ischemic 
myocardium in the anterior wall is akinetic (arrows). 
However, during isovolumic relaxation (c) while the non-
ischemic regions start to relax, myocardial thickening can 
be is seen in the anterior LV wall (arrows), i.e. post-systolic 
contraction of the ischemic myocardium. Coronary 
angiography showed significant stenosis in the proximal 
LAD coronary artery. 
 
Fig. 7. MRI study in an 18 year old male with acute chest 
pain in which acute myocarditis was diagnosed. Mid 
ventricular short axis T2-weighted STIR image shows 
edema (increased signal intensities) in the lateral wall 
(arrows, a) and short and vertical long-axis ce-MRI show 
typical subepicardial enhancement in the lateral wall 
(arrows, b,c). Journal of Medicine and Life Vol. 4, Issue 4, October‐December 2011 
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to 25 minutes post contrast administration, we refer to it 
as  late ce-MRI opposed to early ce-MRI which is 
generally used to depict MVO. Moreover, the extent of 
enhancement is significantly influenced by the time 
between time of infarct and imaging, with a significant 
decrease in extent of enhancement between day 1 and 
day 7 post-infarction [24,49]. 
Myocardial salvage by early reperfusion 
therapy can be objectively assessed by relating the extent 
of necrosis to the extent of myocardium at risk [51]. 
Myocardial salvage can be determined by SPECT, but 
this technique suffers from several limitations. Similar 
information are non-invasively obtained using a 
combination of edema imaging and late ce-MRI. The 
myocardium at risk exceeds the irreversible damaged 
myocardium, but both are closely related [52,53]. 
Typically, edema involves the entire width of the 
myocardial wall, whereas the transmural spread of 
necrosis is variable. Francone et al. showed in an MRI 
study that increasing ischemia time does not affect the 
extent of myocardium at risk but results in an increasing 
infarct size and subsequently decreased myocardial 
salvage [54]. The amount of salvaged myocardium is 
markedly reduced after 90 min of coronary occlusion, 
while early mechanical reperfusion and maintenance of 
antegrade or collateral flow independently preserves 
myocardial salvage primarily through a reduction of infarct 
transmurality [54,55]. Myocardial salvage is independently 
associated with early ST-segment resolution, and is an 
independent predictor of adverse LV remodeling and 
major cardiac events [51-53]. Early reperfusion can result 
in  aborted infarction, thus achieving the ultimate 
myocardial salvage [56]. Although the diagnosis of 
aborted MI is based on complete resolution of initial ST-
segment elevation and lack of significant increase in 
cardiac enzymes, a combined edema imaging and ce-
MRI approach can help in visualizing aborted MI. 
 
Assessment of Myocardial Infarction Severity 
Infarct size is a crucial determinant of adverse 
LV remodeling. Thus, estimation of the amount of 
irreversibly lost myocardium is imperative to assess 
infarct severity and has short and long term prognostic 
value [57]. Late ce-MRI is a well-validated, accurate and 
reproducible tool for sizing acute, healing and healed 
infarcts [58,59]. Due to its high spatial resolution, enabling 
depiction of small MI’s, late ce-MRI is considered the 
reference imaging modality for infarct sizing  and is 
increasingly being used to determine the relationship 
between infarct size, ventricular remodeling and patient 
outcome [26,58,60,61]. As for acute MI patients, in 
patients with healed or unrecognized myocardial 
infarctions, the presence and extent of scarred tissue on 
ce-MRI shows strong and independent association with 
major adverse cardiac events and cardiac mortality [62-
64]. 
Infarct transmurality is another important 
parameter to be taken into consideration when assessing 
infarct severity.  As it has been shown, early restoration of 
myocardial perfusion might limit the transmural wave of 
necrosis and salvage the jeopardized, viable myocardium 
in the outer, subepicardial layers [54]. Ce-MRI enables 
the accurate determination of infarct transmurality and is 
superior to other techniques such as SPECT imaging 
[24,26]. Infarct transmurality can be expressed visually 
using a semi-quantitative score (1: 0%, 2: 0-25%, 3: 26-
50%, 4: 51-75%, 5: 76-100% of total wall thickness) or 
using an automated quantification approach [65,66]. 
Several ce-MRI based studies have shown that increased 
infarct transmurality is related to lack of inotropic reserve 
and impaired recovery of contractile function, and is 
associated with more pronounced post-infarct wall 
thinning, aneurysm formation and adverse ventricular 
remodeling [49,67-69]. In patients with healed infarcts and 
ventricular dysfunction, scar transmurality as determined 
by ce-MRI, predicts functional recovery post-
revascularization and patient survival [13,63]. 
Microvascular obstruction or No-Reflow. 
Even with early, successful and sustained restoration of 
coronary flow in the culprit coronary artery, between 5 and 
50% of STEMI patients show lack of restoration of blood 
flow at myocardial level. This no-reflow phenomenon is 
secondary to microvascular obstruction (MVO) and has 
a complex, multifactorial pathogenesis including: distal 
embolization, ischemia-reperfusion injury, and individual 
coronary microcirculation predisposition to injury [4,70]. 
No reflow increases with the duration of ischemia time, is 
related to more severe myocardial damage and is 
independently associated with lack of functional recovery, 
adverse ventricular remodeling and worse patient 
outcome [54,68,69,71-74].       
No-reflow can be assessed during primary PCI 
with Thrombolysis In Myocardial Infarction (TIMI) flow 
grade and myocardial blush grade (MBG) post-
reperfusion, by ST-segment elevation resolution early 
post-reperfusion, and can be better quantified by 
noninvasive imaging techniques such as myocardial 
contrast echocardiography and ce-MRI [70]. Ce-MRI has 
become the preferential technique for MVO depiction and 
has been validated against pathologic studies using 
specific staining (thioflavin-S). On ce-MRI no reflow is 
visualized as a central or subepicardial, hypo-intense, 
dark region within the enhanced, bright area of infarcted 
myocardium and is clearly distinguishable from 
completely reperfused infarcts presenting as 
homogeneous enhancement (Fig. 8).  
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Studies using early ce-MRI have shown a 
progressive increase in size for the hypo-intense region 
corresponding to no reflow (up to 3-fold) during the first 48 
hours, suggesting progressive microvascular damage 
after reperfusion [75]. Beyond 2 days, the progress 
causing no-reflow expansion most likely stabilizes and 
persists at least till 9 days post-infarction [76].  
To appreciate the extent of MVO, early ce-MRI 
should be performed, i.e. the first 1-4 minutes, following 
intravenous contrast administration. First-pass perfusion 
imaging and late ce-MRI can also be used for MVO 
imaging. On first-pass perfusion MVO is recognized by 
the presence of hypo-enhanced, dark region (perfusion 
defect) despite successful restoration of coronary flow in 
the infarct-related artery. Using late ce-MRI MVO is 
visualized in the same way as for early ce-MRI, i.e. dark 
areas within the bright enhanced infarct area, but usually 
is smaller in size in the late sequences. For example, in 
52 reperfused ST-elevation MI’s, we found a reduction in 
number (32 versus 27 patients) and spatial extent of no-
reflow (36±25% versus 16±14% late enhancement 
extent) between early and late ce-MRI [77].  
Reperfusion injury and microvascular damage, in 
their most severe form, can be associated with significant 
interstitial extravasation of red blood cells, i.e. post-
reperfusion intramyocardial hemorrhage [ 78]. 
Hemorrhagic myocardium has a typical heterogeneous 
appearance on T2-weighted MRI (edema imaging) due 
to formation of hemoglobin breakdown products 
containing iron and their paramagnetic effects. This 
heterogeneous appearance is visualized as a hypo-
intense core with a peripheral hyperintense rim, while, 
non-hemorrhagic infarcts present as areas with 
homogeneously increased signal intensity in the 
myocardium at risk [79]. In a study of 98 patients with 
reperfused STEMI’s, we found intra-myocardial 
hemorrhage in 25% of patients  [80]. Patients with 
hemorrhagic infarcts had a lower pre-TIMI flow, higher 
cardiac enzymes, larger infarct size and greater infarct 
transmurality, larger no-reflow zone, and a lower 
myocardial salvage index. Intra-myocardial hemorrhage 
was an independent predictor of adverse LV remodeling 
regardless of the initial infarct size. It should be 
emphasized that intra-myocardial hemorrhage has a close 
and intricate relation with MVO. On the one hand, the 
degree of microvascular injury underlies extravasation of 
red blood cells and on the other hand, intra-myocardial 
hemorrhage may worsen tissue turgor and aggravate the 
severity and extent of MVO.  
Right ventricular (RV) infarction, usually an 
expression of a biventricular acute MI is characterized by 
a faster and better functional recovery than LV due to a 
more favourable oxygen demand/supply profile for the 
former [81]. Lack of RV recovery, however, is associated 
with persistent hemodynamic compromise and high 
mortality rate [82]. MRI is increasingly being used to study 
RV ischemic injury in MI patients, though assessment of 
reversible and irreversible ischemic injury in a thin and 
trabeculated RV wall is challenging (Fig. 4).  Despite 
some limitations, MRI has contributed not only to a better 
depiction but also to a better understanding of RV 
ischemic injury. It has become clear that current 
established techniques for RV infarct detection, such as 
clinical investigation, ECG with right precordial leads, and 
echocardiography underestimate the true incidence of RV 
ischemic injury in acute inferior LV infarcts, with RV 
inferior wall enhancement in approximately 50% of 
patients. Moreover, RV ischemic injury is not limited to 
inferior infarcts but is often found in anterior LV infarcts as 
well [83]. Taking into account that up to 30% of the RV 
free wall is perfused by the LAD coronary artery, a 
considerable portion of the RV myocardium is at risk in 
LAD infarcts. Fortunately, the RV myocardial salvage 
post-reperfusion is large and the resultant RV infarct size 
small [83,84]. In a recent study we found at 4-month 
follow-up post-infarction a significant decrease in extent 
and frequency of RV myocardial enhancement [83]. 
Potential explanations include volume shrinkage due to 
infarct healing but other mechanisms such as acute, 
temporary enhancement of the reversibly injured portion 
of the jeopardized myocardium should be equally 
considered.  
 
In Vivo Morphologic Validation of ECG using Contrast 
Enhanced MRI 
In the past, a great deal of knowledge about 
ECG changes in acute coronary syndromes and IHD was 
based on pathologic correlations in animal work and 
autopsy studies. Ce-MRI has allowed a reassessment 
and reinterpretation of our common understanding of the 
ECG [65].  
Fig. 8. Extensive lateral MI in 68 year-old man studied 1 
week and 4 months after the acute event. Proximal Cx 
coronary artery occlusion treated by primary PCI but 
complicated by no reflow. Cine MRI in horizontal long-axis 
shows thickened LV lateral wall due to myocardial edema 
and inflammation in the acute phase (a), followed by 
marked wall thinning at 4 months (d). Horizontal long-axis 
and midventricular short-axis late ce-MRI show an 
extensive subendocardial no reflow zone at 1 week 
(arrows b,c) and transmural enhancement of the lateral 
wall (arrowheads, b, c, e, f). Both papillary muscles are 
involved (no reflow at 1 week and enhancement at 4 
months). At follow-up strong, homogeneous enhancement 
of the scarred myocardium (arrowheads, e). Journal of Medicine and Life Vol. 4, Issue 4, October‐December 2011 
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First, regarding Q waves and transmurality, 
several MRI studies have shown that the primary 
determinant of the presence of a Q-wave is the total size 
of the underlying infarction rather than its transmural 
extent [85-87].  
Second, ECG-derived estimates of infarct size 
correlate at best, only modestly with ce-MRI, 
overestimating small infarcts and underestimating large 
infarcts [88]. Importantly, the lateral LV territories are 
electrically silent and therefore may present with little 
ECG alteration [89]. Recently, a multi-specialist team has 
defined a new terminology of the LV walls and proposed a 
new ECG classification of Q-wave myocardial infarction 
based on cardiac MRI and angiographic correlations [90].  
 
Patterns of Enhancement Depending on Infarct 
Location 
As already mentioned above, myocardial 
enhancement after ce-MRI is non-specific for MI. Two 
important features attribute with a higher degree of 
certainty the pattern of ce-MRI enhancement to IHD.     
First, regardless of the MI location, the pattern of 
enhancement always presents as spreading outward from 
the endocardium. Whether the infarction itself is 
subendocardial or transmural, the subendocardium is 
always involved.  
Second, the infarction is always located within 
the anatomical territory supplied by one coronary artery, 
and the intensity of abnormalities increases towards the 
distal perfusion territory of that coronary artery.     
The use of these two criteria allows the physician 
to differentiate between MI and enhancement seen in 
other diseases such as in myocarditis, which is known to 
present a more diffuse of multifocal enhancement pattern, 
often subepicardially located and not infrequently 
accompanied by pericardial involvement, i.e. pericardial 
enhancement (Fig. 7). 
In inferior infarctions, the enhancement is usually 
located in the basal and mid-ventricular inferior LV wall 
and may extend towards the lateral LV wall as well 
towards the RV inferior wall. Lateral MI’s are typically 
located in the lateral LV wall and sometimes may be 
extensive involving the entire lateral wall. Anterior infarcts 
are variable in size and typically involve the anterior or 
anteroseptal wall showing a variable extension to the 
septum and anterolateral wall. Longitudinally they usually 
involve the mid – and apical LV portion and LV apex but 
may extend toward the basal LV portion. Smaller sized 
infarctions, often at atypical locations (e.g. mid-septum), 
can be seen when coronary artery side branches are 
involved (Fig. 9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Infarct-related Complications  
Cardiac MRI also represents a valuable tool in 
the diagnosis of complications related to MI, such as 
aneurysm formation, thrombus formation, valve leakage, 
associated pericardial effusion or post-infarction 
pericarditis. This technique is useful to depict and 
differentiate true from pseudo ventricular aneurysms. 
Besides differences in anatomy between the two, false 
aneurysms invariably show pericardial enhancement [91]. 
Ventricular thrombi are easily missed on transthoracic 
echocardiography especially when located in the LV apex 
or when trapped within the endocardial trabeculations. 
Using a combination of ce-MRI and cine MRI, ventricular 
thrombi are well demonstrated and differentiated from 
slow flow [92]. Thrombi are best visualized on early ce-
MRI sequences and they appear as intracavitary, hypo-
intense filling-defects [93] (Fig. 10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
High-spatial resolution 3D ce-MRI techniques 
offer improved detection for papillary muscle infarction 
as a substrate for mitral valve regurgitation (Fig. 8) [94]. 
MI associated pericarditis can also be depicted by late 
ce-MRI showing bright, enhanced pericardium with or 
without pericardial fluid [95]. MRI may be occasionally 
Fig. 9. MRI study in a 47 year-old female with LV septal 
wall motion abnormalities (incidental findings) on 
echocardiography probably due to an embolic occlusion of 
a septal LAD coronary artery branch. Midventricular short-
axis and horizontal long-axis cine MRI (a,c) and short-axis 
tagging MRI (b) show marked mid septal wall thinning with 
dyskinetic wall motion (arrows). First-pass perfusion MRI 
(d) and late ce-MRI (e,f) show a perfusion defect (d) and 
transmural enhancement (e, f) within the thinned 
myocardium (arrows). 
Fig. 10. Old anterior MI in 75 year old man presenting with 
heart failure symptoms. Horizontal long-axis cine MRI (a) 
and early (b) ce-MRI show apical aneurysm with large 
typically hypoenhanced thrombus (arrows, a,b). Late ce-
MRI in the same plane shows apical transmural 
enhancement (arrowheads, c). Journal of Medicine and Life Vol. 4, Issue 4, October‐December 2011 
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helpful in detecting rare complications such as ventricular 
septal defects or intramural dissecting myocardial 
hemorrhage [96]. 
Looking at treatment-related complications, ce-
MRI can depict peri-procedural necrosis after 
successful PCI and coronary bypass surgery and can 
help for a better understanding of its underlying 
mechanisms [97,98]. MRI yields promise to accurately 
depict subtle myocardial damage related to other 
procedures like trauma, chest compression and external 
defibrillation [99] (Fig. 11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chronic Ischemic Cardiomyopathy and myocardial 
viability assessment 
Patients with chronic ischemic 
cardiomyopathy have single or multivessel CAD and 
dilated, dysfunctional ventricles containing a mixture of 
different ischemic substrates ((i.e. stunned, ischemic, 
hibernating, necrotic, scarred myocardium) in the 
same/different perfusion territory. Viability assessment is 
of utmost importance in deciding whether a patient may 
benefit from a revascularization procedure, with the aim of 
improving regional and global ventricular function, 
negative remodeling, symptoms, exercise capacity and 
long term prognosis [100]. 
Among the different tools available for viability 
assessment, MRI has emerged as one of the preferential 
techniques by combining information about wall thickness 
and myocardial contractility reserve, used also by 
echocardiography,  with the noninvasive visualization of 
even subtle amounts of myocardial scar formation 
[26,101]. Viability imaging with MRI is only part of a more 
comprehensive approach which involves evaluation of 
ventricular volumes and global function, visualization and 
quantification of associated valvular heart disease (i.e. 
mitral regurgitation), and depiction of complications such 
as ventricular aneurysms or thrombus formation [92]. 
A first approach is the measurement of 
segmental end-diastolic wall thickness (EDWT). The 
degree of wall thinning secondary to MI healing and scar 
formation is related to the degree of infarct transmurality. 
This approach appears very sensitive (95%), but not 
specific (41%) for prediction of functional recovery, 
indicating that thinned myocardium (< 6mm) has a low 
likelihood to improve function after revascularization and 
accurately reflects scar tissue. While a substantial 
percentage of segments with preserved wall thickness do 
not improve in function following revascularization, 
probably due to the presence of subendocardial 
infarctions, thinned myocardial segments may undergo a 
process of “reverse remodeling” after successful 
myocardial revascularization with recovery of function and 
regain in regional wall thickness [100,102].  
A second approach is the contractile reserve 
assessment during low dose dobutamine stress. In 
patients with chronic LV dysfunction, hibernating 
myocardial segments typically show a “biphasic 
response” with improved contractility during low-dose (5-
10 µg/kg per minute) dobutamine infusion, followed by a 
worsening of function [103]. Dobutamine stress MRI for 
viability testing has good specificity (83%) but moderate 
sensitivity (74%), values that are in line with those of 
dobutamine echocardiography [100,102]. 
Contrast-enhanced MRI, the third approach, 
detects scar tissue but not viability. In brief, the likelihood 
of improvement in regional contractility after 
revascularization decreases progressively as the 
transmural extent of enhancement before 
revascularization increases. 78% of dysfunctional 
segments without enhancement showed improved 
contractility postrevascularization, compared to 2% of 
dysfunctional segments with scar tissue extending >75% 
of the LV wall in a study by Kaandorp et al. This technique 
had an excellent sensitivity (95%) but a low specificity 
(45%)  [104]. The low specificity is related to 
subendocardial infarcts in which it is unclear whether the 
non-enhanced subepicardial myocardium contains 
normal, viable or jeopardized myocardium.  
Because none of the above approaches is 
perfect in neither predicting nor excluding functional 
recovery after revascularization, an integrated use of 
MRI techniques may improve diagnostic accuracy. 
Kaandorp et al. proposed to start with ce-MRI to depict 
myocardial scarring and determine the transmural extent. 
Then, in segments with an intermediate extent of scar 
tissue (transmurality 25-50%), in which the likelihood of 
recovery is uncertain, dobutamine stress MRI may be 
used to differentiate between those with versus those 
without contractility reserve [104].  
Fig. 11. MRI study in a 66 year asymptomatic male with an 
old history of severe thoracic trauma (car accident) in 
which routine echocardiography showed an abnormal 
structure over the LV lateral wall. Horizontal long-axis cine 
(a) and T1-weighted (b) MRI show a well delineated, 
homogeneous and hyperintense pericardial mass (arrows, 
a,b). Late ce-MRI in the same imaging plane shows 
pericardial enhancement with the hypoenhancement of the 
mass (arrows,  c) and adjacent transmural lateral 
myocardial wall enhancement (arrowheads,  c). The 
combination of hyperintense signal on T1w with 
hypoenhancement on late ce-MRI is typical for old blood 
supporting the diagnosis of posttraumatic pericardial 
hematoma with secondary extrinsic compression and 
scarring on the adjacent LV wall. Journal of Medicine and Life Vol. 4, Issue 4, October‐December 2011 
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Prognosis Assessment 
Any clinical perspective about an imaging 
technique should involve its role in patient prognosis 
assessment and management. There is growing evidence 
that cardiac MRI is an increasingly important tool in the 
management of cardiovascular disease [105].  
In patients with suspected CAD, a negative 
stress perfusion MRI study yields a high negative 
predictive value for future major adverse cardiac events; 
whereas stress perfusion defects or dobutamine stress 
induced WMA’s predict subsequent cardiac events 
[64,106,107]. Moreover, in patients without a history of MI 
but with clinical suspicion of CAD, the presence of 
myocardial enhancement even in small amounts, 
reflecting ischemia-related myocardial scarring, carries an 
increased risk for future major adverse cardiac events 
[62,64].  
In low to intermediate risk unstable angina 
patients, adenosine stress perfusion MRI is a more 
accurate predictor of future cardiac events than traditional 
cardiac risk factors [108]. Moving forward to acute MI, in 
STEMI patients, MRI has become the reference technique 
for infarct sizing. Moreover, because of its unique 
capability for characterization of the infarct and 
jeopardized myocardium MRI is a valuable tool in the 
assessment of other factors associated with a poor 
prognosis, besides infarct size)  [8,11,57,109]. These 
include MVO,  post-reperfusion myocardial hemorrhage, 
the peri-infarct area,  and myocardial salvage 
[51,53,73,76,80,110].  Also in patients with NSTEMI, 
persistent MVO is an independent predictor of major 
cardiac events [111].  
      In  ischemic cardiomyopathy patients with 
severely reduced LVEF, the extent of myocardial 
enhancement is associated with increased mortality or the 
need for cardiac transplantation. In a study involving 857 
consecutive patients with and without LV dysfunction and 
a median follow-up of 4.4 years, myocardial enhancement 
using a myocardial scar index (i.e. sum of transmurality 
scores of all 17 segments divided by 17) was a strong and 
independent predictor of all cause mortality/cardiac 
transplantation [63].  
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